At least seven people were killed in two shootings at Half Moon Bay, two days after a gunman killed at least 11 people at a dance hall in Monterey Park.
Two of the most forward-thinking agencies in the United States are joining forces to foster the development of advanced space propulsion. A fireside chat on the new collaboration is scheduled for Tuesday morning, and you can watch it live right here.
Garmin hasn’t yet had a dedicated electrocardiogram (ECG) app despite the health focus of its wearables, but it’s filling that gap today. The company has introduced a simply-titled ECG App that, like equivalents on other devices, can study your heart rhythm and look for atrial fibrillation (aka AFib). If there are signs of trouble, you can sync your results with Garmin Connect and create a report you can share with healthcare providers.
You will have to be fussy about your choice of devices to use this software right away. Garmin is currently offering the app only to Venu 2 Plus owners in the US. They’ll need to update both their firmware and the Connect app. The company plans to add support for more devices and countries over time, but that will require further government approvals. Don’t expect your running watch to get an ECG app for a while.
This is the first app Garmin has cleared with the US Food and Drug Administration. As with similar apps, it’s not meant to be a definitive verdict on your heart health and won’t detect cardiac arrest. Your watch only offers functionality comparable to a single-lead ECG — your doctor can use a multi-lead system that will present a more accurate picture of your condition. Garmin VP Dan Bartel notes that this app is mainly helpful for spotting AFib in the early stages, when it’s “difficult to detect” at a clinic.
There are plenty of alternatives if ECG is a must-have feature. Apple, Google (including Fitbit), Samsung, Withings and others have had the technology in their watches for a while. It’s difficult to complain about having more choices, though, and this may be appealing if you prefer Garmin’s overall fitness and health tracking capabilities.
Microsoft is making a “multibillion-dollar” investment that will lead to wider uses of OpenAI’s technology, as well as more robust behind-the-scenes support. Microsoft has launched OpenAI-powered features, like natural language programming and a DALL-E 2 graphic design tool. OpenAI uses Microsoft’s infrastructure to train its best-known systems, including DALL-E 2 and the popular ChatGPT bot. ChatGPT is coming to Azure soon. However, don’t expect anyone to see ChatGPT in Bing – at least not yet. The expansion may help Microsoft seize a competitive advantage. Google reportedly sees ChatGPT as a threat to its search business,
The versatile AI chatbot is having a surge in popularity. The existing version already had more than one million users around December 2022. That’s probably grown, too – and Microsoft wouldn’t mind a piece of that.
With its last batch of MacBook Pros, Apple gave its more demanding fans everything they wanted: tons of ports, lots of power and genuinely great screens. This time, it’s just a straightforward chip upgrade, featuring the new M2 Pro and M2 Max. They’re faster, as you’d expect, and they deliver a few features power users may appreciate, like 8K video output and support for WiFi 6E. The new MacBook Pro 14-inch isn’t a dramatic departure from the last model, but the new chips will be incredibly useful to creative professionals.
He took the witness stand again to defend his ‘funding secured’ tweets.
Elon Musk said he could’ve sold his SpaceX shares to take Tesla private when he took the witness stand again to defend his 2018 “funding secured” tweets in a lawsuit filed by the automaker’s shareholders. According to CNBC, Musk proclaimed: “SpaceX stock alone meant ‘funding secured’ by itself. It’s not that I want to sell SpaceX stock but I could have, and if you look at the Twitter transaction – that is what I did. I sold Tesla stock to complete the Twitter transaction. And I would have done the same here.”
The plaintiffs’ lawsuit is based on Musk’s infamous 2018 tweets in which he said he was “considering taking Tesla private at $420.” The judge in this case has already determined his tweets were “objectively false and reckless.” However, the plaintiffs still have to prove Musk knew his tweets were misleading and caused their losses to win the case. Musk and Tesla previously had to pay the Securities and Exchange Commission $20 million each to settle a separate lawsuit over the same tweets, accusing him of making “false and misleading statements” that could constitute fraud.
Microsoft is stopping sales of Windows 10 downloads on January 31st, according to a product page spotted by The Verge. That date “will be the last day this Windows 10 download [and all-important license keys] are offered for sale,” according to Microsoft. However, it will continue to support Windows 10 with security updates until it’s discontinued for good in October 2025. Windows 10 launched in 2015 and will be discontinued exactly 10 years later. The company announced its end date in June 2021 as part of its “modern lifecycle policy,” just before the launch of Windows 11.
We’re expecting Apple to reveal a mixed reality headset in the coming months. It’ll be Apple’s first new product category since Apple Watch, which debuted in 2015. Bloomberg’s Mark Gurman has shared details about what to expect from the product, which may be called Reality Pro. The standalone device will have an interface similar to an iPhone and iPad and the option to pin widgets to the home screen. Alternatively, it may be used as an external display for a connected Mac. Along with Siri voice commands, there’ll be the option to use a Mac, iPhone or iPad keyboard to enter text on the xrOS operating system, according to the report.
For one-on-one chats in which both participants wear a Reality Pro, the report also suggests FaceTime will render realistic versions of their face and body. Yes, that means legs! The device is rumored to appear ahead of Apple’s Worldwide Developers Conference in June, with a release to follow in fall. The price, though, may put many off. The headset could retail for around $3,000. That’s twice as much as the Meta Quest Pro.
If you haven’t heard of ChatGPT, the uncanny new AI-driven chatbot from San Francisco-based OpenAI, here is a quick primer on everything you need to know about the controversial new program.
“He was not talking about his wife of 31 years, the mother of his two children,” the MSNBC anchor said of the House speaker’s promise to the far-right congresswoman.
Amazon has launched a new subscription service that will let customers in the US get as many eligible medications as they need for $5 a month. The new service called RxPass is part of the e-commerce giant’s Pharmacy business that originally launched in 2020 as a two-day prescription drug delivery offering for Prime users. That makes RxPass a $5 add-on for Prime, which sets users back $139 a year or $15 a month in the US.
While it doesn’t look quite as affordable bundled with Prime pricing, the RxPass program does offer medications for 80 common health conditions, including high blood pressure, acid reflux, anemia and even depression, diabetes, breast cancer and dementia. At the moment, it has 60 generic medications in its list — all of which require a valid prescription — and subscribers can choose to have them delivered for free either on a monthly or a quarterly basis.
Take note that customers will need to pay $5 out of pocket, since the service does not take insurance like Amazon Pharmacy does for purchases outside of the program. People who are enrolled to Medicare, Medicaid and any other government healthcare program will not be able to sign up for RxPass, as well, though they can still use their government insurance when purchasing medicine from Pharmacy.
For people with multiple conditions paying a lot more than $5 a month for their medications out of pocket, RxPass could be worth trying out, especially if they already have Prime. Those interested may want to take a look at the service’s full medication list first to see if it does offer what they need before heading to the Pharmacy website or the Amazon app to sign up.
This is site is run by Sascha Endlicher, M.A., during ungodly late night hours. Wanna know more about him? Connect via Social Media by jumping to about.me/sascha.endlicher.